Marino Scherillo (@pusallo) 's Twitter Profile
Marino Scherillo

@pusallo

Director of Cardiology & CCU SAN PIO Hospital
Benevento - 🇮🇹 Italy
Azienda Ospedaliera di Rilievo Nazionale e
di Alta Specializzazione DEA II⁰ Livello

ID: 4031529196

calendar_today24-10-2015 12:19:58

1,1K Tweet

138 Followers

360 Following

Jasmine Sethi (@jasminenephro) 's Twitter Profile Photo

💈Pillars in Nephrology 🫘 4💈of Diabetes+CKD-RASi/SGLT2i/GLP1RA/Non steroidal MRA 4 💈 of Heart failure+CKD-RASi/SGLT2i/MRA/B blocker 4 💈 of IgA Nephropathy 👇

💈Pillars in Nephrology 🫘

4💈of Diabetes+CKD-RASi/SGLT2i/GLP1RA/Non steroidal MRA

4 💈 of Heart failure+CKD-RASi/SGLT2i/MRA/B blocker 

4 💈 of IgA Nephropathy 👇
CardioTeca (@cardioteca) 's Twitter Profile Photo

🆕 Hipersensibilidad a la Aspirina en pacientes con enfermedad cardiovascular aterosclerótica: Revisión. 📕 JACC 📁 Resumen del artículo en cardioteca.com/cardiologia-cl…

🆕 Hipersensibilidad a la Aspirina en pacientes con enfermedad cardiovascular aterosclerótica: Revisión.

📕 JACC
📁 Resumen del artículo en cardioteca.com/cardiologia-cl…
The Heart (@zheart11768530) 's Twitter Profile Photo

🔴Novel and Emerging LDL-C Lowering Strategies: A New Era of Dyslipidemia Management⤵️ #2024Review #openaccess 🔹mdpi.com/2077-0383/13/5… #Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros #MedX

🔴Novel and Emerging LDL-C Lowering Strategies: A New Era of Dyslipidemia Management⤵️ #2024Review #openaccess 

🔹mdpi.com/2077-0383/13/5…
 #Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros  #MedX
NEJM (@nejm) 's Twitter Profile Photo

In patients with heart failure with preserved ejection fraction and obesity, treatment with tirzepatide led to a lower risk of death from cardiovascular causes or worsening heart-failure events than placebo. Full SUMMIT trial results: nej.md/4hRGaTY #AHA24

In patients with heart failure with preserved ejection fraction and obesity, treatment with tirzepatide led to a lower risk of death from cardiovascular causes or worsening heart-failure events than placebo. Full SUMMIT trial results: nej.md/4hRGaTY 

#AHA24
The Heart (@zheart11768530) 's Twitter Profile Photo

🔴Diabetic Nephropathy: Update on Pillars of Therapy Slowing Progression #openaccess #2023Review 🏛 4 Pillars of Therapy 1. RAASi 2. SGLT2i 3. NS-MRA - Finerenone 4. GLP-1RA - Semaglutide diabetesjournals.org/care/article/4…

🔴Diabetic Nephropathy: Update on Pillars of Therapy Slowing Progression #openaccess #2023Review

🏛 4 Pillars of Therapy 
         1. RAASi
         2. SGLT2i
         3. NS-MRA - Finerenone
         4. GLP-1RA - Semaglutide

diabetesjournals.org/care/article/4…
Davide Capodanno (@dfcapodanno) 's Twitter Profile Photo

Are all stents the same for high bleeding risk (HBR) patients? BioFreedom, Resolute Onyx, Synergy, and Xience are approved for HBR patients by both the European Commission and FDA. While Orsiro Mission has strong evidence for HBR use, it lacks specific HBR regulatory approval.

Are all stents the same for high bleeding risk (HBR) patients? BioFreedom, Resolute Onyx, Synergy, and Xience are approved for HBR patients by both the European Commission and FDA. While Orsiro Mission has strong evidence for HBR use, it lacks specific HBR regulatory approval.
American College of Cardiology (@accintouch) 's Twitter Profile Photo

🗝️ Shared decision making for ICDs should highlight the survival benefit associated w/ them but also discuss possible complications associated w/ the device. Read more key points on #epICD therapy for primary prevention in #HFrEF: bit.ly/3ORpJtp #JACCHF JACC Journals

🗝️ Shared decision making for ICDs should highlight the survival benefit associated w/ them but also discuss possible complications associated w/ the device.

Read more key points on #epICD therapy for primary prevention in #HFrEF: bit.ly/3ORpJtp #JACCHF

<a href="/JACCJournals/">JACC Journals</a>
Felice Gragnano (@felicegragnano) 's Twitter Profile Photo

Is the #Sidney4 the conclusive evidence for #ticagrelor monotherapy in acute coronary syndromes? 🧭 thelancet.com/journals/lance… The Lancet Marco Valgimigli #Cardiology #CardioEd

EHJ Editor-in-Chief (@ehj_ed) 's Twitter Profile Photo

"Non-traditional risk factors for atrial fibrillation: epidemiology, mechanisms, and strategies": explore how unexpected factors impact atrial fibrillation and innovative approaches to prevention and treatment. doi.org/10.1093/eurhea… @ESCardio European Society of Cardiology Journals #AF

"Non-traditional risk factors for atrial fibrillation: epidemiology, mechanisms, and strategies": explore how unexpected factors impact atrial fibrillation and innovative approaches to prevention and treatment. 
doi.org/10.1093/eurhea…
@ESCardio <a href="/ESC_Journals/">European Society of Cardiology Journals</a> #AF
MIЯVΛƬ #IC (@mirvatalasnag) 's Twitter Profile Photo

Image guided CHIP w IVL & Impella CP .. complète revascularisation of a NSTEMI in an octogenarian KFAFHCards What is the current evidence for PCI in this age group❓ SENIOR RITA NEJM nejm.org/doi/full/10.10… Professor Vijay Kunadian FIRE 🔥 nejm.org/doi/full/10.10… Simone Biscaglia

The Heart (@zheart11768530) 's Twitter Profile Photo

🔴Evolving Management of Low‐Density Lipoprotein Cholesterol: A Personalized Approach to Preventing ASCVD Across the Risk Continuum #2023Review #openaccess 🔹ahajournals.org/doi/full/10.11… #CardioTwitter #CardioEd #Lipids #CVrisk #LDL

🔴Evolving Management of Low‐Density Lipoprotein Cholesterol: A Personalized Approach to Preventing ASCVD Across the Risk Continuum #2023Review #openaccess 

🔹ahajournals.org/doi/full/10.11…
#CardioTwitter #CardioEd #Lipids #CVrisk #LDL
The Heart (@zheart11768530) 's Twitter Profile Photo

🔴Contemporary treatment options in HFpEF⤵️ #2024Review European Society of Cardiology Journals 🔹academic.oup.com/ehjcimaging/ar… #Diagnosis #Cardiology #ECG #EKG #Brugada #Syndrome #Table #Types #Morphology #ALiEM #Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd

🔴Contemporary treatment options in HFpEF⤵️ #2024Review <a href="/ESC_Journals/">European Society of Cardiology Journals</a>

🔹academic.oup.com/ehjcimaging/ar…
#Diagnosis #Cardiology #ECG #EKG #Brugada #Syndrome #Table #Types #Morphology #ALiEM #Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd
The Heart (@zheart11768530) 's Twitter Profile Photo

🔴2024 ACC/AHA Perioperative Guidelines⤵️ ❤️10 take-home points #ACCAHAPerioperativeGuidelines 🔹ahajournals.org/doi/10.1161/CI… #Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros #MedX #cardiovascular

🔴2024 ACC/AHA Perioperative Guidelines⤵️  
❤️10 take-home points  #ACCAHAPerioperativeGuidelines

🔹ahajournals.org/doi/10.1161/CI…
 #Cardiology #FOAMed #MedEd #medstudent #paramedic #Cardiology #CardioEd #medtwitter #meded #CardioTwitter #cardiotwiteros  #MedX #cardiovascular
Davide Capodanno (@dfcapodanno) 's Twitter Profile Photo

TAVI has become a key alternative to surgical aortic valve replacement, supported by strong evidence from randomized trials across all surgical risk levels. The balloon-expandable SAPIEN and self-expanding CoreValve/Evolut valves are established standards, with emerging valve

TAVI has become a key alternative to surgical aortic valve replacement, supported by strong evidence from randomized trials across all surgical risk levels. The balloon-expandable SAPIEN and self-expanding CoreValve/Evolut valves are established standards, with emerging valve
American College of Cardiology (@accintouch) 's Twitter Profile Photo

RIVAWAR trial: Rivaroxaban was found to be as effective and safe as warfarin in resolving post #cvMI left ventricular thrombus at three months. #ACC25 Get full details here: bit.ly/3G0eSMk

RIVAWAR trial: Rivaroxaban was found to be as effective and safe as warfarin in resolving post #cvMI left ventricular thrombus at three months. #ACC25

Get full details here: bit.ly/3G0eSMk
Felice Gragnano (@felicegragnano) 's Twitter Profile Photo

📣 Clopidogrel outperforms aspirin as chronic monotherapy after PCI - better ischemic protection without increasing bleeding risk 👨‍⚕️💊 💥 P2Y12 inhibitors strike again! 💥 📌 SMART-CHOICE 3 is now online in The Lancet 👉 thelancet.com/journals/lance… Marco Valgimigli #Cardiology #ACC25